Welcome to the Blood and Marrow Transplantation & Cellular Therapy Division. We are a nationally recognized center of excellence, fully accredited by the Foundation for the Accreditation of Cellular Therapy (FACT) and a proud member of the Blood and Marrow Transplant Clinical Trials Network of the National Cancer Institute.

Our state-of-the-art team is comprised of 14 dedicated Faculty, working alongside our outstanding clinical care team of talented fellows, residents, nurse practitioners, physician assistants, and expert nursing and lab staff.  Together we are aligned and work in unison to provide the best possible care for our patients here at Stanford.

Our Division is committed to performing cutting edge research exploring the basic biology of hematopoietic stem cells and effector T cells such as natural killer cells, regulatory T cells, cytotoxic T cells and B cells with the aim of exploring translational research opportunities wherever possible. We are supported by grants from the National Institutes of Health including a Program Project Grant in its 30th year of funding as well as foundation support from Institutions like the California Institute of Regenerative Medicine and the National Marrow Donor Program. The Division runs a cell processing laboratory where all clinical material is prepared for transplantation and where complex cell separation and expansion protocols can be accomplished. We pride ourselves in training physician scientists and performing translational research to find better approaches for the treatment of our patients and advancement of the field.

We welcome the opportunity to serve your patients and are always available for consultation and referral. Thank you for the opportunity and trust in providing the best possible care supported by the strongest science for your patients.

David Miklos, MD, PhD
Professor of Medicine and Division Chief